More Whitepapers
-
WhitepaperA software‑supported, AI‑assisted workflow for optimising LC gradient methods
Shimadzu introduces a novel automated artificial intelligence-driven HPLC method.
-
WhitepaperThe critical role of CCI in drug development and manufacturing
This whitepaper provides a detailed examination of Lonza’s holistic, data-driven approach to CCI, developed in collaboration with industry experts and applied across our global network for parenteral combination products.
-
WhitepaperTCS revolutionize clinical trial monitoring and data analysis with AR/VR-driven immersive analytics
AR/VR solution for visualizing multi-dimensional data in 3D. Explore sites on a 3D globe to detect trends and anomalies with ease.
-
WhitepaperStrategies for endotoxin testing of RNA-LNP
Overcome matrix interferences in RNA–LNP endotoxin testing with LAL-based methods & recombinant factor C assays. Learn more in this whitepaper.
-
WhitepaperAI - a game changer in unifying clinical data
The use of AI technology in unifying clinical data across systems for making clinical trials more effective, safer and more efficient.
-
WhitepaperAccurate and Reproducible Quantitation of xC/UV/MS Data from Any Instrument
Learn how Medtronic processes and quantifies their xC/UV/MS data using the quantitation workflow in MS Workbook Suite.
-
WhitepaperImproving Method Transfer Outcomes
A collaboration with Pfizer to create a tool to ensuring seamless method transfer between labs.
-
Whitepaper
Deepening Digitalization in Drug Discovery at PTC Therapeutics
PTC Therapeutics accelerates drug discovery process by integrating physicochemical property predictions into their Dotmatics ELN.
-
WhitepaperAccelerating Process Chemistry
Process chemists can increase their efficiency by accessing process, analytical, and chemical data from across their organization using Luminata.
-
WhitepaperStandardization of Analytical Data: Best Practices
Learn about available formats for analytical data standardization, limitations, and how to ensure data is usable by lab scientists and AI/ML.
-
WhitepaperNSF Launches ‘Compliance Unlocked’ Podcast Series
NSF invites pharmaceutical professionals to tune in to its new groundbreaking podcast series “Compliance Unlocked” and join the conversation on critical industry issues.
-
WhitepaperCell and Gene Therapy Containment
Overcoming Challenges in Cell and Gene Therapy Containment.
-
WhitepaperNSF’s quality management maturity (QMM) assessment model
NSF’s quality management maturity (QMM) assessment model: future-proofing quality and supporting supply chain robustness
-
WhitepaperUnderstanding and Applying Updated FDA Guidance
Understanding and Applying the Updated FDA Guidance: Inspection of Injectable Products for Visible Particulates.
-
WhitepaperRegulatory Authority Inspection Comparison
A guide on what to expect during a regulatory inspection and the differences in the approach taken by three of the main regulatory authorities and PIC/S.
-
WhitepaperApplication note: The need for rapid methods in the compounding pharmaceutical industry
This application note explores rapid microbial methods and balancing patient care, quality products, and safe shelf lives for unique formulations.
-
WhitepaperSelecting Fill/Finish Manufacturing Technologies
With a growing pipeline of biologics, increase in vaccine production, and small batch sizes targeting small patient populations, there’s increasing demand for advanced manufacturing tech.
-
WhitepaperWhitepaper: What to expect from a regulatory inspection, an NSF expert guide
Regulatory inspections can be challenging, but proper preparation turns them into opportunities for improvement and compliance demonstration.
-
WhitepaperWhitepaper: Risk-Based Approach to Development - Injectable Combination Product
Drug-device combination products offer advantages for patients but are complex and challenging to develop. Establish a holistic approach to DDCP development and assess and manage risk throughout the process.
-
WhitepaperWhitepaper: Optimise organisational culture & quality maturity
Whitepaper - Optimising organisational culture and quality maturity is crucial in promoting consistent, reliable business processes and to minimise supply disruptions.